Mirum Pharmaceuticals
MIRM
39 hedge funds and large institutions have $166M invested in Mirum Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
71.72% more ownership
Funds ownership: 0% → 71.72% (+72%)
Top Buyers
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$51.4M |
| 2 |
FM
Frazier Management
Seattle,
Washington
|
+$43.8M |
| 3 |
DM
Deerfield Management
New York
|
+$42.3M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$30M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$14M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIG
26
American International Group
New York
| $17K | +$20.8K | +1,699 | New |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $9K | +$10.9K | +886 | New |
|
28
JP Morgan Chase
New York
| $9K | +$11.3K | +925 | New |
|
29
Morgan Stanley
New York
| $7K | +$8.43K | +687 | New |
|
|
GHCM
30
Glen Harbor Capital Management
San Diego,
California
| $6K | +$7.09K | +578 | New |
|
31
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $6K | +$8.73K | +712 | New |
|
|
MCIM
32
Meadow Creek Investment Management
Atlanta,
Georgia
| $5K | +$5.84K | +476 | New |
|
|
EP
33
Elkfork Partners
Portland,
Oregon
| $4K | +$4.59K | +374 | New |
|
|
TAM
34
Tyers Asset Management
Austin,
Texas
| $3K | +$3.34K | +272 | New |
|
35
Citigroup
New York
| $2K | +$1.46K | +119 | New |
|
36
Wells Fargo
San Francisco,
California
| $2K | +$2.66K | +217 | New |
|
|
AIP
37
Ameritas Investment Partners
Lincoln,
Nebraska
| $2K | +$2.76K | +225 | New |
|
|
CAW
38
Cornerstone Advisors (Washington)
Bellevue,
Washington
| $1K | +$1.04K | +85 | New |
|
39
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1.21K | +99 | New |
|
MIRM Hedge Fund Activity: Q3 2019 in Review
39 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q3 2019, worth a combined $166M.
Buyers outnumbered sellers: 39 funds opened new MIRM positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was NEA Management Company, opening a new position worth an estimated $51.4M.
- 39 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $166M of Mirum Pharmaceuticals stock for Q3 2019.
- 39 funds opened new Mirum Pharmaceuticals positions in Q3 2019 and 0 closed out, a net change of +39 holders.
- The largest Mirum Pharmaceuticals buyer in Q3 2019 was NEA Management Company, an estimated $51.4M added.
Based on aggregated 13F filings for Q3 2019.